Gillian Worthy

1.3k total citations
17 papers, 875 citations indexed

About

Gillian Worthy is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gillian Worthy has authored 17 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gillian Worthy's work include Cardiac Imaging and Diagnostics (3 papers), Wound Healing and Treatments (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Gillian Worthy is often cited by papers focused on Cardiac Imaging and Diagnostics (3 papers), Wound Healing and Treatments (2 papers) and Cardiovascular Function and Risk Factors (2 papers). Gillian Worthy collaborates with scholars based in United Kingdom, Netherlands and United States. Gillian Worthy's co-authors include Karel Pavelká, Guido Valesini, Robert Landewé, E. Hensor, Paul Emery, Josef S Smolen, J. Nam, Maya H Buch, Ronald van Vollenhoven and Kevin Winthrop and has published in prestigious journals such as The British Journal of Psychiatry, Clinical Chemistry and Annals of the Rheumatic Diseases.

In The Last Decade

Gillian Worthy

17 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gillian Worthy United Kingdom 13 230 212 208 133 129 17 875
Alan J. Bridges United States 18 257 1.1× 55 0.3× 211 1.0× 85 0.6× 135 1.0× 40 957
Jannie J. Abbink Netherlands 17 53 0.2× 213 1.0× 75 0.4× 554 4.2× 149 1.2× 23 1.2k
Terry McCarthy Singapore 14 137 0.6× 78 0.4× 56 0.3× 42 0.3× 67 0.5× 41 848
Blanca Rueda‐Medina Spain 21 282 1.2× 49 0.2× 81 0.4× 139 1.0× 109 0.8× 78 1.2k
Paras Karmacharya United States 22 454 2.0× 231 1.1× 206 1.0× 156 1.2× 100 0.8× 81 1.3k
Sakir Ahmed India 18 273 1.2× 36 0.2× 116 0.6× 144 1.1× 124 1.0× 94 1.1k
Orit Schieir Canada 15 600 2.6× 47 0.2× 113 0.5× 76 0.6× 144 1.1× 49 1.1k
M. Horowitz United States 16 97 0.4× 45 0.2× 306 1.5× 266 2.0× 157 1.2× 32 1.2k
Ho Yin Chung Hong Kong 15 609 2.6× 128 0.6× 80 0.4× 51 0.4× 64 0.5× 67 1.0k
Nihal Özdemir Türkiye 17 60 0.3× 391 1.8× 230 1.1× 148 1.1× 221 1.7× 114 1.2k

Countries citing papers authored by Gillian Worthy

Since Specialization
Citations

This map shows the geographic impact of Gillian Worthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Worthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Worthy more than expected).

Fields of papers citing papers by Gillian Worthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Worthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Worthy. The network helps show where Gillian Worthy may publish in the future.

Co-authorship network of co-authors of Gillian Worthy

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Worthy. A scholar is included among the top collaborators of Gillian Worthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Worthy. Gillian Worthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Grimm, Sabine, Rob Riemsma, Nigel Armstrong, et al.. (2020). Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 39(2). 171–180. 5 indexed citations
2.
Grimm, Sabine, Debra Fayter, Bram Ramaekers, et al.. (2019). Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(10). 1195–1207. 8 indexed citations
3.
Grimm, Sabine, Nigel Armstrong, Bram Ramaekers, et al.. (2018). Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. 37(5). 655–667. 10 indexed citations
4.
Gilbody, Simon, Sally Brabyn, Karina Lovell, et al.. (2017). Telephone-supported computerised cognitive–behavioural therapy: REEACT-2 large-scale pragmatic randomised controlled trial. The British Journal of Psychiatry. 210(5). 362–367. 63 indexed citations
5.
Tóth, Peter P., Gillian Worthy, Shravanthi R. Gandra, et al.. (2017). Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia. Journal of the American Heart Association. 6(10). 70 indexed citations
6.
7.
Wolff, Robert, Steve Ryder, Alberto Bossi, et al.. (2015). A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. European Journal of Cancer. 51(16). 2345–2367. 63 indexed citations
8.
Forbes, Carol, Gillian Worthy, Julie Harker, et al.. (2014). Dose Efficiency of Erythropoiesis-Stimulating Agents for the Treatment of Patients With Chemotherapy-Induced Anemia: A Systematic Review. Clinical Therapeutics. 36(4). 594–610.e4. 14 indexed citations
9.
Ball, Stephen G., et al.. (2012). Hypertensive left ventricular hypertrophy. Journal of Hypertension. 30(10). 2039–2046. 21 indexed citations
10.
Watson, Judith, Arthur R Kang’ombe, Marta Soares, et al.. (2011). Use of weekly, low dose, high frequency ultrasound for hard to heal venous leg ulcers: the VenUS III randomised controlled trial. BMJ. 342(mar08 2). d1092–d1092. 37 indexed citations
11.
12.
Chambers, Duncan, Gillian Worthy, Lindsey Myers, et al.. (2010). Glycopeptide vs. Non-Glycopeptide Antibiotics for Prophylaxis of Surgical Site Infections: A Systematic Review. Surgical Infections. 11(5). 455–462. 20 indexed citations
13.
Mather, Adam N, Andrew Crean, Gillian Worthy, et al.. (2010). Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 12(1). 61–61. 41 indexed citations
14.
Nam, J., Kevin Winthrop, Ronald van Vollenhoven, et al.. (2010). Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Annals of the Rheumatic Diseases. 69(6). 976–986. 284 indexed citations
15.
Barth, Julian H., Amanda Farrin, Maria Efthymiou, et al.. (2010). Change in Serum Lipids after Acute Coronary Syndromes: Secondary Analysis of SPACE ROCKET Study Data and a Comparative Literature Review. Clinical Chemistry. 56(10). 1592–1598. 21 indexed citations
16.
Mather, Adam N, Andrew Crean, Gillian Worthy, et al.. (2010). Influence of peri-infarct dysglycaemia on myocardial infarct size and its effect on cardiovascular outcome as determined by cardiovascular magnetic resonance imaging. Journal of Cardiovascular Magnetic Resonance. 12(S1). 1 indexed citations
17.
Soares, Marta, C Iglesias, John M. Bland, et al.. (2009). Cost effectiveness analysis of larval therapy for leg ulcers. BMJ. 338(mar19 2). b825–b825. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan J. Bridges Breakdown of academic impact, for papers by Jannie J. Abbink Breakdown of academic impact, for papers by Terry McCarthy Breakdown of academic impact, for papers by Blanca Rueda‐Medina Breakdown of academic impact, for papers by Paras Karmacharya Breakdown of academic impact, for papers by Sakir Ahmed Breakdown of academic impact, for papers by Orit Schieir Breakdown of academic impact, for papers by M. Horowitz Breakdown of academic impact, for papers by Ho Yin Chung Breakdown of academic impact, for papers by Nihal Özdemir
Rankless by CCL
2026